178 related articles for article (PubMed ID: 30391388)
1. Infective Endocarditis of Patent Foramen Ovale Closure Device Presenting as an Amoeboid-Like Mass.
Yamaoka H; Takaya Y; Watanabe N; Akagi T; Nakagawa K; Toh N; Kotani Y; Kasahara S; Ito H
JACC Cardiovasc Interv; 2018 Nov; 11(22):2337-2338. PubMed ID: 30391388
[No Abstract] [Full Text] [Related]
2. Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature.
Amedro P; Soulatges C; Fraisse A
Catheter Cardiovasc Interv; 2017 Feb; 89(2):324-334. PubMed ID: 27641431
[TBL] [Abstract][Full Text] [Related]
3. Never too late for amplatzer endocarditis: Key role of cardiac CT imaging.
Wang TKM; Gabriel R; Kang N; Looi JL
J Cardiovasc Comput Tomogr; 2020; 14(5):e24-e25. PubMed ID: 30389340
[No Abstract] [Full Text] [Related]
4. Subacute endocarditis of an atrial septal closure device in a patient with a patent foramen ovale.
Krantz SB; Lawton JS
Ann Thorac Surg; 2014 Nov; 98(5):1821-3. PubMed ID: 25441794
[TBL] [Abstract][Full Text] [Related]
5. Fusion Imaging During the Interventional Closure of Patent Foramen Ovale and Atrial Septal Defects: Mandatory or Superfluous?
Afzal S; Veulemans V; Kleinebrecht L; Stuewe D; Balzer J; Polzin A; Nijhof N; Kelm M; Zeus T; Hellhammer K
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1543-1545. PubMed ID: 29680347
[No Abstract] [Full Text] [Related]
6. Patent foramen ovale closure with NobleStitch EL system in a case of Ebstein's anomaly after a failed device closure attempt.
Giordano M; Gaio G; Marzullo R; Scognamiglio G; Altobelli I; Russo MG; Sarubbi B
J Cardiovasc Med (Hagerstown); 2024 Jul; 25(7):559-562. PubMed ID: 38625819
[No Abstract] [Full Text] [Related]
7. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
[TBL] [Abstract][Full Text] [Related]
8. Stroke due to late device thrombosis following successful percutaneous patent foramen ovale closure.
Korabathina R; Thaler DE; Kimmelstiel C
Catheter Cardiovasc Interv; 2012 Sep; 80(3):498-502. PubMed ID: 21953702
[TBL] [Abstract][Full Text] [Related]
9. Thrombus in a Hypercoagulable Patient Following Patent Foramen Ovale Closure With the Gore Septal Occluder.
Luc JGY; Bakar SN; Kiaii B; Sridhar K
JACC Cardiovasc Interv; 2018 Jun; 11(11):1108-1109. PubMed ID: 29778728
[No Abstract] [Full Text] [Related]
10. Successful Percutaneous Transcatheter Patent Foramen Ovale Closure Through The Right Internal Jugular Vein Using Stiff Amplatzer Catheter With A Reshaped Tip.
Fanari Z; Hammami S; Hopkins JT
Del Med J; 2016 Aug; 88(8):238-241. PubMed ID: 28751787
[TBL] [Abstract][Full Text] [Related]
11. A dancing balloon in the right atrium - A rare presentation of MSSA cardiac device related infected endocarditis.
Marchel M; Gasecka A; Czub P; Kochanowski J; Opolski G
Clin Microbiol Infect; 2020 Aug; 26(8):1044-1045. PubMed ID: 32006690
[No Abstract] [Full Text] [Related]
12. [Interventional closure of persistent foramen ovale in patients after crytogenic stroke].
Chatterjee T; Akin I; Nienaber CA; Rehders TC; Ortak J; Chatterjee A; Ince H
Praxis (Bern 1994); 2010 Oct; 99(20):1203-15. PubMed ID: 20931496
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis, fracture, and percutaneous removal of a patent foramen ovale closure device 1 month after successful deployment.
Gori T; Schräder R; Genth-Zotz S
Catheter Cardiovasc Interv; 2010 Apr; 75(5):778-81. PubMed ID: 20091815
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive retrieval of patent foramen ovale closure device after device migration to the descending aorta.
Basoor AS; Cotant JF; Halabi AR; DeGregorio M; Chughtai H; Patel KC
Tex Heart Inst J; 2012; 39(4):582-4. PubMed ID: 22949785
[TBL] [Abstract][Full Text] [Related]
15. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory pseudothrombus on a patent foramen ovale occluder device.
MacKerrow S; Farb A; Sullivan R
Tex Heart Inst J; 2011; 38(6):710-3. PubMed ID: 22199445
[TBL] [Abstract][Full Text] [Related]
17. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
[No Abstract] [Full Text] [Related]
18. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up.
Luani B; Markovic S; Krumsdorf U; Rottbauer W; Wöhrle J
EuroIntervention; 2015 May; 11(1):85-91. PubMed ID: 25572024
[TBL] [Abstract][Full Text] [Related]
20. Transhepatic approach to closure of patent foramen ovale: report of 2 cases in adults.
Hussain J; Strumpf R; Ghandforoush A; Jamal A; Diethrich E
Tex Heart Inst J; 2010; 37(5):553-6. PubMed ID: 20978566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
